Commentary
Clinical Pharmacology & Therapeutics (2001) 69, 189–193; doi: 10.1067/mcp.2001.114672
Counterfeit and substandard drugs
Marcus M. Reidenberg MD1 and Bradley A. Conner MD1
1Weill Medical College of Cornell University
Correspondence: Marcus M. Reidenberg, MD, Weill Medical College of Cornell University, 1300 York Avenue, New York, NY 10021
Received 11 December 2000; Accepted 25 January 2001.
